This inventor holds 1 USPTO granted patent. Top assignees: Medizinische Universitat Wien, Universitat Fur Bodenkultur Wien. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ingo Lämmermann: Innovator in Senescent Cell Elimination
Introduction
Ingo Lämmermann is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of cellular biology, particularly in the area of senescent cell elimination. His innovative work has led to the development of a unique composition aimed at addressing the challenges posed by senescent cells in various biological contexts.
Latest Patents
Ingo Lämmermann holds 1 patent for his invention titled "Compositions for the elimination of senescent cells." This invention relates to a composition that includes one or more inhibitors capable of inhibiting at least two of cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2), and lipoxygenase. Additionally, it encompasses inhibitors that target enzymes with arachidonate-CoA ligase activity, specifically long-chain-fatty-acid-CoA ligases (ACSL) 1, 3, 4, 5, 6, SLC27A2, or ACSBG2. The invention also provides methods for identifying senescent cells and candidate compounds for their selective elimination.
Career Highlights
Throughout his career, Ingo Lämmermann has worked with prestigious institutions such as the University of Natural Resources and Life Sciences, Vienna, and the Medical University of Vienna. His research has focused on the implications of senescent cells in aging and various diseases, contributing to a deeper understanding of cellular processes.
Collaborations
Ingo has collaborated with esteemed colleagues, including Johannes Grillari and Vera Pils. These partnerships have enhanced his research and expanded the impact of his innovations in the scientific community.
Conclusion
Ingo Lämmermann's work in the field of senescent cell elimination showcases his dedication to advancing scientific knowledge and developing practical solutions. His contributions are paving the way for future innovations in cellular biology and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile